Skip to main content
Annals of Intensive Care
Fig. 2 | Annals of Intensive Care

Fig. 2

From: Early sevoflurane sedation in severe COVID-19-related lung injury patients. A pilot randomized controlled trial

Fig. 2

Highlights renal plasma markers up to day 8 in patients subjected to continuous intravenous sedation or a 48 h intervention with sevoflurane. Plasmatic creatinine concentration (2 A), urea concentration (2 B), and glomerular filtration rate (2 C) are illustrated. Values from patients undergoing renal replacement therapy have been excluded. The dots represent mean values; error bars indicate the standard deviation

Back to article page